FDA — authorised 23 January 2015
- Application: NDA206317
- Marketing authorisation holder: ROCKWELL MEDICAL INC
- Local brand name: TRIFERIC
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
🇺🇸 Triferic in United States
FDA authorised Triferic on 23 January 2015
Marketing authorisation
Other Other approved in United States
Frequently asked questions
Is Triferic approved in United States?
Yes. FDA authorised it on 23 January 2015.
Who is the marketing authorisation holder for Triferic in United States?
ROCKWELL MEDICAL INC holds the US marketing authorisation.